Citigroup’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,956
Closed -$28.9K 5006
2024
Q1
$28.9K Buy
1,956
+384
+24% +$5.67K ﹤0.01% 4162
2023
Q4
$21.1K Buy
1,572
+1,548
+6,450% +$20.8K ﹤0.01% 4218
2023
Q3
$296 Sell
24
-3,093
-99% -$38.1K ﹤0.01% 4509
2023
Q2
$38.3K Buy
+3,117
New +$38.3K ﹤0.01% 4096
2019
Q3
Sell
-571
Closed -$3K 5306
2019
Q2
$3K Hold
571
﹤0.01% 4982
2019
Q1
$3K Sell
571
-3,101
-84% -$16.3K ﹤0.01% 4954
2018
Q4
$11K Hold
3,672
﹤0.01% 4608
2018
Q3
$15K Sell
3,672
-2,415
-40% -$9.87K ﹤0.01% 4624
2018
Q2
$24K Sell
6,087
-1,056
-15% -$4.16K ﹤0.01% 4316
2018
Q1
$45K Buy
7,143
+5,037
+239% +$31.7K ﹤0.01% 3825
2017
Q4
$17K Sell
2,106
-1,350
-39% -$10.9K ﹤0.01% 4326
2017
Q3
$40K Sell
3,456
-2,997
-46% -$34.7K ﹤0.01% 3753
2017
Q2
$63K Sell
6,453
-14,015
-68% -$137K ﹤0.01% 3498
2017
Q1
$497K Sell
20,468
-36,489
-64% -$886K ﹤0.01% 2414
2016
Q4
$1.83M Buy
56,957
+46,523
+446% +$1.49M ﹤0.01% 1931
2016
Q3
$522K Buy
10,434
+6,987
+203% +$350K ﹤0.01% 2410
2016
Q2
$146K Sell
3,447
-9,899
-74% -$419K ﹤0.01% 3081
2016
Q1
$879K Buy
13,346
+10,852
+435% +$715K ﹤0.01% 2178
2015
Q4
$155K Sell
2,494
-8,023
-76% -$499K ﹤0.01% 3252
2015
Q3
$704K Buy
10,517
+5,466
+108% +$366K ﹤0.01% 1965
2015
Q2
$490K Sell
5,051
-1,106
-18% -$107K ﹤0.01% 2164
2015
Q1
$576K Sell
6,157
-1,122
-15% -$105K ﹤0.01% 2172
2014
Q4
$647K Buy
7,279
+4,955
+213% +$440K ﹤0.01% 2205
2014
Q3
$160K Sell
2,324
-1,138
-33% -$78.3K ﹤0.01% 2806
2014
Q2
$198K Sell
3,462
-1,615
-32% -$92.4K ﹤0.01% 2594
2014
Q1
$201K Sell
5,077
-2,093
-29% -$82.9K ﹤0.01% 2865
2013
Q4
$302K Buy
7,170
+4,638
+183% +$195K ﹤0.01% 2784
2013
Q3
$76K Buy
2,532
+1,701
+205% +$51.1K ﹤0.01% 3350
2013
Q2
$44K Buy
+831
New +$44K ﹤0.01% 3839